Kooij Louise Frederika
SEC insider (Form 3/4/5 filer). CIK 0002004379. Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS). 45 reported Form 4/5 transactions since Sep 2024; latest on Jul 20, 2026. Located in NAARDEN.
Companies Kooij Louise Frederika has filed insider reports for
- NewAmsterdam Pharma Co N.V. (NAMS): Officer, Chief Accounting Officer
Kooij Louise Frederika
CIK: 0002004379
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NewAmsterdam Pharma Co N.V.
Discretionary Trading P&L
Holdings
Transaction History (45 total)
- Jul 20, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect2.9K shares at avg. $31.71$92K - Jul 20, 2026NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect80K shares at avg. $11.17$894K - Jul 20, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect70.2K shares at avg. $29.96$2.1M - Jul 20, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect31.9K shares at avg. $31.05$990K - Jul 20, 2026NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect25K shares at avg. $11.90$298K - Jun 22, 2026NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect25K shares at avg. $10.90$273K - Jun 22, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect300 shares at avg. $30.73$9K - Jun 22, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect39.7K shares at avg. $30.20$1.2M - Jun 22, 2026NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect15K shares at avg. $11.90$179K - May 26, 2026NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect60K shares at avg. $10.00$600K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 20, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 2,915 | $31.71 | $92,435 | Direct |
| Jul 20, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 80,000 | $11.17 | $893,600 | Direct |
| Jul 20, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 70,200 | $29.96 | $2,103,192 | Direct |
| Jul 20, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 31,885 | $31.05 | $990,029 | Direct |
| Jul 20, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 25,000 | $11.90 | $297,500 | Direct |
| Jun 22, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 25,000 | $10.90 | $272,500 | Direct |
| Jun 22, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 300 | $30.73 | $9,219 | Direct |
| Jun 22, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 39,700 | $30.20 | $1,198,940 | Direct |
| Jun 22, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 15,000 | $11.90 | $178,500 | Direct |
| May 26, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 60,000 | $10.00 | $600,000 | Direct |
1-10 of 45 transactions